Developing new tools for discovering cancer drugs

New Chemical Tools for Covalent Drug Discovery

NIH-funded research Dana-Farber Cancer Inst · NIH-11018610

This study is all about developing new tools to see how cancer drugs work with proteins in the body, which could help make these treatments safer and more effective for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11018610 on NIH RePORTER

What this research studies

This research focuses on creating new chemical tools that help identify how cancer drugs interact with proteins in the body. By understanding which proteins are targeted by these drugs and how they bind to them, researchers aim to improve the safety and effectiveness of cancer therapies. The team will synthesize and test these tools to gather important data on drug interactions, which can lead to better risk assessments and more promising drug candidates for clinical trials.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from new therapeutic options.

Not a fit: Patients who are not currently undergoing cancer treatment or those with non-cancerous conditions may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective cancer treatments.

How similar studies have performed: Other research has shown promise in using similar chemical tools for drug discovery, indicating a potential for success in this approach.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agentsanti-cancer druganti-cancer therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.